Related Experiment Video
Updated: Sep 5, 2025

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
The relation between second-generation antipsychotics and laxative use in elderly patients with schizophrenia
Ching-Hua Lin1,2, Hsin-Yi Lin3, Ta-Chun Lin4
1Department of Psychiatry, Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, Kaohsiung, Taiwan.
Concomitant laxative use is common in elderly schizophrenia patients on second-generation antipsychotics (SGAs). Factors like female gender, mood stabilizers, and diabetes increased use, with clozapine showing the highest rates.
Area of Science:
- Geriatric Psychiatry
- Pharmacology
- Gastroenterology
Background:
- Elderly patients with schizophrenia often experience constipation.
- Second-generation antipsychotics (SGAs) are commonly prescribed for schizophrenia.
- Concomitant laxative use in this population requires investigation.
Purpose of the Study:
- To identify factors associated with laxative use in elderly schizophrenia patients on SGAs.
- To analyze trends in laxative use over time.
Main Methods:
- Retrospective analysis of 1727 elderly schizophrenia patients discharged between 2006-2019.
- Multivariate logistic regression to determine factors associated with laxative use.
- Cochrane-Armitage trend test for temporal analysis.
Main Results:
- 42.4% of patients used concomitant laxatives.
- Female gender, mood stabilizer use, and diabetes mellitus were associated with increased laxative use.
- Clozapine showed the highest laxative use rate; rates increased from 30.8% to 46.6% over the study period.
Conclusions:
- Laxative use is prevalent in elderly schizophrenia patients on SGAs.
- Consider switching to SGAs with lower constipation risk or discontinuing mood stabilizers if feasible.
- Further research into optimizing gastrointestinal care for this population is warranted.
More Related Videos
04:04Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...